Harmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS)
Chemical Research in Toxicology · 15.07.2024 · 37 (7) · 1155-1170
DOI: 10.1021/acs.chemrestox.4c00093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 26.06.2024. Verfasst von Samantha M Reilly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, United States. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Aerosols. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Health and Human Services.
Abstract (Originalsprache)
In 2012, the U.S. Food & Drug Administration (FDA) published an established list of 93 harmful and potentially harmful constituents (HPHCs) targeting four tobacco product types (cigarettes, cigarette tobacco, roll-your-own tobacco, smokeless tobacco). In 2016, the FDA finalized the deeming rule to regulate electronic nicotine delivery systems (ENDS). However, knowledge gaps exist regarding whether certain HPHCs are present in ENDS e-liquids and aerosols. We identified and addressed these gaps by conducting literature searches and then experimentally quantifying HPHCs in the e-liquid and aerosol of 37 ENDS brands based on gaps in the literature. The literature searches identified 66 e-liquid HPHCs and 68 aerosol HPHCs that have limited to no information regarding the quantifiability of these constituents. A contracted ISO 17025 accredited laboratory performed the HPHC quantifications. The availability of validated analytical methods in the contracted laboratory determined the HPHCs included in the study scope (63/66 for e-liquids, 64/68 for aerosols). Combining the results from the quantifications and literature searches, 36 (39%) and 34 (37%) HPHCs were found quantifiable (≥limit of quantification [LOQ]) in ENDS e-liquids and aerosols, respectively, with 25 HPHCs being quantifiable in both matrices. Quantifiability results imply potential HPHC transfers between matrices, leaching from components, or formations from aerosol generation. The study results can inform the scientific basis for manufacturers and regulators regarding regulatory requirements for HPHC reporting. The HPHC quantities can also inform evaluations of the public health impact of ENDS and public communications regarding ENDS health risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, United States.
ORCID-Profile: Samantha M Reilly, Tianrong Cheng, Charles Feng
Förderung
- U.S. Department of Health and Human Services
Zitieren
APA
Reilly, S. M., Cheng, T., Feng, C., & Walters, M. J. (2024). Harmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS). Chemical Research in Toxicology, 37(7), 1155-1170. https://doi.org/10.1021/acs.chemrestox.4c00093
Vancouver
Reilly SM, Cheng T, Feng C, Walters MJ. Harmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS). Chemical Research in Toxicology. 2024;37(7):1155-1170. doi:10.1021/acs.chemrestox.4c00093
BibTeX
@article{Reilly2024,
author = {Reilly, Samantha M and Cheng, Tianrong and Feng, Charles and Walters, Matthew J},
title = {Harmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS)},
journal = {Chemical Research in Toxicology},
year = {2024},
volume = {37},
number = {7},
pages = {1155--1170},
doi = {10.1021/acs.chemrestox.4c00093}
}
EUVIMED